Clinicopathologic features and prognostic grouping of gastrointestinal stromal tumors (GISTs) in Pakistani patients: an institutional perspective
- PMID: 29996918
- PMCID: PMC6042430
- DOI: 10.1186/s13104-018-3562-8
Clinicopathologic features and prognostic grouping of gastrointestinal stromal tumors (GISTs) in Pakistani patients: an institutional perspective
Abstract
Objectives: Gastrointestinal stromal tumors (GISTs) are rare tumors of gastrointestinal tract, prognosis of which largely depends upon histopathologic characteristics of resection specimens, which were not widely studied in our population. Therefore we aimed to evaluate the histopathologic characteristics of GISTs in our population and their prognostic grouping according to college of American pathologist's guidelines.
Results: Mean age of patients was 53.4 years (18-71 years). 92% of cases were of primary GISTs and stomach was the most common site (57.7%). 75% of cases were of spindle cell morphology and 53.8% belonged to high risk prognostic group. Comparison of stomach and intestinal GISTs showed that intestinal GISTs were found to be of high grade (70%) and of high risk prognostic group (75 and 80%) compared to stomach GISTs (43% were of high risk prognostic group), however this finding was not statistically significant. GISTs are infrequent gastrointestinal tumors but early diagnosis and identification of adverse histological features are key to successful treatment. We found a large majority of GISTs to be located in stomach, however intestinal GISTs were found more likely to be associated with adverse prognostic parameters. However more large scale studies are warranted to establish this finding.
Keywords: Epitheloid GIST; GISTs; Gastrointestinal stromal tumors; Spindle cell GIST.
Figures
Similar articles
-
Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.Cancer. 2011 Nov 1;117(21):4916-24. doi: 10.1002/cncr.26079. Epub 2011 Mar 31. Cancer. 2011. PMID: 21456019
-
Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.Am J Surg Pathol. 2009 Sep;33(9):1267-75. doi: 10.1097/PAS.0b013e3181a13e99. Am J Surg Pathol. 2009. PMID: 19440146
-
Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.Ann Diagn Pathol. 2007 Feb;11(1):39-45. doi: 10.1016/j.anndiagpath.2006.03.014. Ann Diagn Pathol. 2007. PMID: 17240306
-
Diagnostic and treatment strategy for small gastrointestinal stromal tumors.Cancer. 2016 Oct 15;122(20):3110-3118. doi: 10.1002/cncr.30239. Epub 2016 Aug 1. Cancer. 2016. PMID: 27478963 Free PMC article. Review.
-
[Clinical and morphological characteristics of gastrointestinal stromal tumors].Arkh Patol. 2017;79(4):48-55. doi: 10.17116/patol201779448-55. Arkh Patol. 2017. PMID: 28791999 Review. Russian.
Cited by
-
Mutational characteristics of gastrointestinal stromal tumors: A single-center analysis of 302 patients.Oncol Lett. 2021 Feb;21(2):174. doi: 10.3892/ol.2021.12435. Epub 2021 Jan 4. Oncol Lett. 2021. PMID: 33552291 Free PMC article.
-
Associations of CD34, Ki67, layer of invasion and clinical pathological characteristics, prognosis outcomes in gastrointestinal stromal tumors-a retrospective cohort study.Transl Cancer Res. 2022 Aug;11(8):2866-2875. doi: 10.21037/tcr-22-1777. Transl Cancer Res. 2022. PMID: 36093530 Free PMC article.
-
Clinicopathological, immunohistochemical, molecular-genetic and risk profiles of gastrointestinal stromal tumors in a cohort of Sudanese patients.Afr Health Sci. 2023 Mar;23(1):444-458. doi: 10.4314/ahs.v23i1.47. Afr Health Sci. 2023. PMID: 37545902 Free PMC article.
-
Gastrointestinal stromal tumors with atypical features and presentations: A case series.Int J Surg Case Rep. 2025 Aug;133:111569. doi: 10.1016/j.ijscr.2025.111569. Epub 2025 Jun 26. Int J Surg Case Rep. 2025. PMID: 40609291 Free PMC article.
-
Gastro-intestinal stromal tumor (GIST): Experience from a tertiary care center in a low resource country.Turk J Surg. 2022 Dec 20;38(4):362-367. doi: 10.47717/turkjsurg.2022.5746. eCollection 2022 Dec. Turk J Surg. 2022. PMID: 36875265 Free PMC article.
References
-
- Fülöp E, Marcu S, Milutin D, Borda A. Gastrointestinal stromal tumors: review on morphology, diagnosis and management. Rom J Morphol Embryol. 2009;50(3):319–326. - PubMed
-
- Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden. Cancer. 2005;103(4):821–829. doi: 10.1002/cncr.20862. - DOI - PubMed
-
- Bucher P, Villiger P, Egger JF, Buhler LH, Morel P. Management of gastrointestinal stromal tumors: from diagnosis to treatment. Swiss Med Wkly. 2004;134:145–153. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources